{"name":"Azienda Sanitaria-Universitaria Integrata di Udine","slug":"azienda-sanitaria-universitaria-integrata-di-udine","ticker":"","exchange":"","domain":"","description":"Azienda Sanitaria-Universitaria Integrata di Udine is a public healthcare organization in Italy that integrates hospital and university functions, focusing on patient care, research, and medical education.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fluconazol","genericName":"Fluconazol","slug":"fluconazol","indication":"Candidal Urinary Tract Infection","status":"marketed"}]}],"pipeline":[{"name":"Fluconazol","genericName":"Fluconazol","slug":"fluconazol","phase":"marketed","mechanism":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","indications":["Candidal Urinary Tract Infection","Candidal septicemia","Candidal vulvovaginitis","Candidemia","Candidiasis of mouth"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}